Featured Products

My Quote Request

No products added yet

6505-01-462-0075

20 Products

SB123

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505014620075

NSN

6505-01-462-0075

View More Info

SB123

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505014620075

NSN

6505-01-462-0075

MFG

ALTHIN GROUP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS ACETATE, GLACIAL PER LITER AND 33.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM PER LITER AND 103.750 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: CENTRISOL BATH
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: MAGNESIUM PER LITER AND 137.000 MILLIEQUIVALENTS SODIUM PER LITER

MK206404

METHYL SALICYLATE O

NSN, MFG P/N

6505014616278

NSN

6505-01-461-6278

View More Info

MK206404

METHYL SALICYLATE O

NSN, MFG P/N

6505014616278

NSN

6505-01-461-6278

MFG

VWR INTERNATIONAL INC DBA VWR SCIENTIFIC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYL SALICYLATE OIL OF WINTERGREEN BT 1 PINT
SPECIAL FEATURES: METHYL SALICYLATE (OIL OF WINTERGREEN); 1 PINT

98-1458

POLYSORBATE 20 SOLU

NSN, MFG P/N

6505014616280

NSN

6505-01-461-6280

View More Info

98-1458

POLYSORBATE 20 SOLU

NSN, MFG P/N

6505014616280

NSN

6505-01-461-6280

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: POLYOXYETHYLENESORBITAN MONOLAURATE (TWEEN 20); 100 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYSORBATE 20 SOLUTION 100ML BT

P1379

POLYSORBATE 20 SOLU

NSN, MFG P/N

6505014616280

NSN

6505-01-461-6280

View More Info

P1379

POLYSORBATE 20 SOLU

NSN, MFG P/N

6505014616280

NSN

6505-01-461-6280

MFG

SIGMA-ALDRICH CORPORATION

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: POLYOXYETHYLENESORBITAN MONOLAURATE (TWEEN 20); 100 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYSORBATE 20 SOLUTION 100ML BT

1A1322

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014616314

NSN

6505-01-461-6314

View More Info

1A1322

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014616314

NSN

6505-01-461-6314

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH NA 154 MEQ/L, CL 154 MEQ/L, APPROX 5.0 PH, 308 MOSMOL/L, GLASS SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00338-0044-02

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014616314

NSN

6505-01-461-6314

View More Info

NDC00338-0044-02

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505014616314

NSN

6505-01-461-6314

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH NA 154 MEQ/L, CL 154 MEQ/L, APPROX 5.0 PH, 308 MOSMOL/L, GLASS SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 12

2D5633

MANNITOL INJECTION,USP

NSN, MFG P/N

6505014616347

NSN

6505-01-461-6347

View More Info

2D5633

MANNITOL INJECTION,USP

NSN, MFG P/N

6505014616347

NSN

6505-01-461-6347

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V MANNITOL ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: OSMITRAL IN WATER
TOTAL PRIMARY CONTAINER QUANTITY: 18

NDC00338-0357-03

MANNITOL INJECTION,USP

NSN, MFG P/N

6505014616347

NSN

6505-01-461-6347

View More Info

NDC00338-0357-03

MANNITOL INJECTION,USP

NSN, MFG P/N

6505014616347

NSN

6505-01-461-6347

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V MANNITOL ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: OSMITRAL IN WATER
TOTAL PRIMARY CONTAINER QUANTITY: 18

DF18

ALCOHOL,USP

NSN, MFG P/N

6505014616569

NSN

6505-01-461-6569

View More Info

DF18

ALCOHOL,USP

NSN, MFG P/N

6505014616569

NSN

6505-01-461-6569

MFG

SIEMENS HEALTHCARE DIAGNOSTICS INC

Description

PRIMARY CONTAINER CONTENT QUANTITY: 120.000 EACH
PRIMARY CONTAINER TYPE: CARTON
SPECIAL FEATURES: 12 MONTH EXPIRATION DATE

5310-04

ELECTROLYTE CONCENTRATE FOR INJECTION

NSN, MFG P/N

6505014619659

NSN

6505-01-461-9659

View More Info

5310-04

ELECTROLYTE CONCENTRATE FOR INJECTION

NSN, MFG P/N

6505014619659

NSN

6505-01-461-9659

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIEQUIVALENTS SODIUM ACTIVE INGREDIENT AND 20.000 MILLIEQUIVALENTS POTASSIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS CALCIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS MAGNESIUM ACTIVE INGREDIENT AND 30.000 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 25 MQ ACETATE; ELECTROLYTE QUANTITIES ARE PER 25 ML; MUST BE DILUTED; PARTIAL FILL 25 ML IN A 30 ML GLASS VIAL; 25 PER PACKAGE, 100 PER CASE
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT

HYPERLYTE R

ELECTROLYTE CONCENTRATE FOR INJECTION

NSN, MFG P/N

6505014619659

NSN

6505-01-461-9659

View More Info

HYPERLYTE R

ELECTROLYTE CONCENTRATE FOR INJECTION

NSN, MFG P/N

6505014619659

NSN

6505-01-461-9659

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIEQUIVALENTS SODIUM ACTIVE INGREDIENT AND 20.000 MILLIEQUIVALENTS POTASSIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS CALCIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS MAGNESIUM ACTIVE INGREDIENT AND 30.000 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 25 MQ ACETATE; ELECTROLYTE QUANTITIES ARE PER 25 ML; MUST BE DILUTED; PARTIAL FILL 25 ML IN A 30 ML GLASS VIAL; 25 PER PACKAGE, 100 PER CASE
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT

NDC00703-5310-04

ELECTROLYTE CONCENTRATE FOR INJECTION

NSN, MFG P/N

6505014619659

NSN

6505-01-461-9659

View More Info

NDC00703-5310-04

ELECTROLYTE CONCENTRATE FOR INJECTION

NSN, MFG P/N

6505014619659

NSN

6505-01-461-9659

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIEQUIVALENTS SODIUM ACTIVE INGREDIENT AND 20.000 MILLIEQUIVALENTS POTASSIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS CALCIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS MAGNESIUM ACTIVE INGREDIENT AND 30.000 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 25 MQ ACETATE; ELECTROLYTE QUANTITIES ARE PER 25 ML; MUST BE DILUTED; PARTIAL FILL 25 ML IN A 30 ML GLASS VIAL; 25 PER PACKAGE, 100 PER CASE
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT

7828-08

RINGER'S IRRIGATION,LACTATED

NSN, MFG P/N

6505014619672

NSN

6505-01-461-9672

View More Info

7828-08

RINGER'S IRRIGATION,LACTATED

NSN, MFG P/N

6505014619672

NSN

6505-01-461-9672

MFG

B BRAUN MEDICAL INC

Description

FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 4

NDC00074-7828-08

RINGER'S IRRIGATION,LACTATED

NSN, MFG P/N

6505014619672

NSN

6505-01-461-9672

View More Info

NDC00074-7828-08

RINGER'S IRRIGATION,LACTATED

NSN, MFG P/N

6505014619672

NSN

6505-01-461-9672

MFG

B BRAUN MEDICAL INC

Description

FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 4

98-1421

L-TYROSINE

NSN, MFG P/N

6505014619898

NSN

6505-01-461-9898

View More Info

98-1421

L-TYROSINE

NSN, MFG P/N

6505014619898

NSN

6505-01-461-9898

MFG

FISHER SCIENTIFIC CO

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: L-TRYOSINE 5GM

AC14064-0050

L-TYROSINE

NSN, MFG P/N

6505014619898

NSN

6505-01-461-9898

View More Info

AC14064-0050

L-TYROSINE

NSN, MFG P/N

6505014619898

NSN

6505-01-461-9898

MFG

FISHER SCIENTIFIC CO

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: L-TRYOSINE 5GM

98-2759

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505014619942

NSN

6505-01-461-9942

View More Info

98-2759

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505014619942

NSN

6505-01-461-9942

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSP 150MG/ML 1ML VIAL
III SUPPLEMENTARY FEATURES: SUBSTITUTE FOR PREFERRED NSN OF 6505-01-529-5618
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 150 MG/ML; 1 ML; VIAL

DEPO-PROVERA

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505014619942

NSN

6505-01-461-9942

View More Info

DEPO-PROVERA

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505014619942

NSN

6505-01-461-9942

MFG

PHARMACIA & UPJOHN COMPANY

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSP 150MG/ML 1ML VIAL
III SUPPLEMENTARY FEATURES: SUBSTITUTE FOR PREFERRED NSN OF 6505-01-529-5618
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 150 MG/ML; 1 ML; VIAL

NDC00009-0746-30

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505014619942

NSN

6505-01-461-9942

View More Info

NDC00009-0746-30

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505014619942

NSN

6505-01-461-9942

MFG

AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSP 150MG/ML 1ML VIAL
III SUPPLEMENTARY FEATURES: SUBSTITUTE FOR PREFERRED NSN OF 6505-01-529-5618
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 150 MG/ML; 1 ML; VIAL

CENTRISOL

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505014620075

NSN

6505-01-462-0075

View More Info

CENTRISOL

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505014620075

NSN

6505-01-462-0075

MFG

ALTHIN GROUP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS ACETATE, GLACIAL PER LITER AND 33.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM PER LITER AND 103.750 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: CENTRISOL BATH
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: MAGNESIUM PER LITER AND 137.000 MILLIEQUIVALENTS SODIUM PER LITER